IDEAYA Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $218.7 | $7.0 | $23.4 | $50.9 | $27.9 |
| Operating income | -$159.3 | -$327.0 | -$134.4 | -$62.5 | -$50.3 |
| Net income | -$113.7 | -$274.5 | -$113.0 | -$58.7 | -$49.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$73.5 | -$251.4 | -$117.6 | -$90.6 | -$58.4 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Shares outstanding 96.5M · Free float 92.2%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.